Amicus
Amicus is a biopharmaceutical company that develops and commercializes medicines for the treatment of metabolic diseases.
Business Model:
Revenue: $323.3M
Employees: 201-500
Industries / Tags:
Detailed Amicus Information
Geographic Data
Address: 3675 Market Street
City: Philadelphia
State: PA
Zip: 19104
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$400M
Raised Total:$843M
Social
Metrics
3,682,461Website Global Rank
3,519Website Monthly Traffic
Twitter Followers
Description
Amicus is a biopharmaceutical company that develops and commercializes medicines for the treatment of metabolic diseases.
Contact Phone:
+12159217600
Contact Email:
Amicus went public on 5/31/2007 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/31/2007
IPO Valuation:
$330M
Ticker Symbol:
FOLD
IPO Price:
$15/share
Amount Raised:
$315M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 9/2018 | Celenex | |
| 8/2015 | Scioderm | |
| 11/2013 | Callidus Biopharma |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
